Health · Full coverage
FDA Approval Opens New Treatment Path for Type 1 Diabetes in Children
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% centerFirst reported by N12 · 13 hours ago
Center 2
What happened
The FDA has approved Tzield for children and teenagers already diagnosed with type 1 diabetes, aiming to slow pancreatic damage and preserve insulin production. Schneider Children’s Medical Center says the treatment could soon reach Israeli patients, but it is not yet in the health basket and is very expensive.
- 01FDA approved Tzield for diagnosed type 1 diabetes in ages 8 to 17.
- 02The drug aims to slow pancreatic damage, not cure diabetes.
- 03Schneider says Israeli children may soon benefit from the treatment.
- 04ADIR uses blood tests to estimate risk with about 85% accuracy.
- 05The drug costs about 500,000 shekels per treatment, and may need two.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Experimental CAR-T Therapy Puts 19-Year-Old With Rare Vasculitis Into Remission2 days agoCan Peanut Allergy Be Reduced in Children and Adults?Jun 10, 2026Unvaccinated Infant in Life-Threatening Condition Saved at Shaare ZedekJun 18, 2026Health Ministry Says Experimental Cancer Treatment Was Unauthorized and MishandledJun 14, 2026Israeli-led study reports major breakthrough in high-risk bladder cancer treatmentJun 14, 2026Genetic Testing Is Transforming Epilepsy CareJun 18, 2026
